GT56-252
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GT56-252, covering 2015-03-05 to 2015-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia [Phase 1, Phase 2]